Accelemed Research Institute
Austin, Texas, United States
Research institute in Austin, Texas
2501 W William Cannon Dr STE 208, Austin, TX 78745
About Accelemed Research Institute
"Accelemed Research Institute is a multi-specialty research center in Austin, TX."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Altimmune, Inc.
2
Inventiva Pharma
2
Allena Pharmaceuticals
1
Clinical Trials at Accelemed Research Institute
During the past decade, Accelemed Research Institute conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Establishing the Safety and Efficacy of Reloxaliase in Patients With Enteric Hyperoxaluria
2019-08-26
2022-05-19
Terminated
92
A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( NATiV3 )
2021-08-19
2026-09-30
Recruiting
1,000
ALT-801 in Diabetic and Non-Diabetic Overweight and Obese Subjects With Non-alcoholic Fatty Liver Disease (NAFLD)
2021-09-30
2022-12-01
Active, not recruiting
72
Placebo-controlled, Proof-of-concept Study to Evaluate the Safety and Efficacy of Lanifibranor Alone and in Combination With SGLT2 Inhibitor EmpaGliflozin in patiEnts With NASH and Type 2 Diabetes Mellitus
2022-06-29
2023-07-01
Recruiting
63
Extension of ALT-801 in Diabetic and Non-Diabetic Overweight and Obese Subjects With (NAFLD)
2022-03-09
2022-11-01
Active, not recruiting
70
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Accelemed Research Institute
According to Clinical.Site data, the most researched conditions in "Accelemed Research Institute" are
"NASH - Nonalcoholic Steatohepatitis" (2 trials), "Non-Alcoholic Fatty Liver Disease" (2 trials), "Diabetes Mellitus, Type 2" (1 trials) and "Enteric Hyperoxaluria" (1 trials). Many other conditions were trialed in "Accelemed Research Institute" in a lesser frequency.
Clinical Trials Intervention Types at Accelemed Research Institute
Most popular intervention types in "Accelemed Research Institute" are "Drug" (5 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (5 trials), "ALT-801" (2 trials), "IVA337" (2 trials), "Empagliflozin" (1 trials) and "Reloxaliase" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Accelemed Research Institute
The vast majority of trials in "Accelemed Research Institute" are
5 trials for "All" genders.
Clinical Trials Status at Accelemed Research Institute
Currently, there are NaN active trials in "Accelemed Research Institute".
undefined are not yet recruiting,
2 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Accelemed Research Institute,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Accelemed Research Institute, 2 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".